| 000 | 01662 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517225501.0 | ||
| 264 | 0 | _c20190314 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/jdv.15177 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDauden, E | |
| 245 | 0 | 0 |
_aPosition statement for the management of comorbidities in psoriasis. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cDec 2018 |
||
| 300 |
_a2058-2073 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnxiety _xepidemiology |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDepression _xepidemiology |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xepidemiology |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xepidemiology |
| 650 | 0 | 4 |
_aKidney Diseases _xepidemiology |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xepidemiology |
| 650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xepidemiology |
| 650 | 0 | 4 |
_aObesity _xepidemiology |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPsoriasis _xepidemiology |
| 700 | 1 | _aBlasco, A J | |
| 700 | 1 | _aBonanad, C | |
| 700 | 1 | _aBotella, R | |
| 700 | 1 | _aCarrascosa, J M | |
| 700 | 1 | _aGonzález-Parra, E | |
| 700 | 1 | _aJodar, E | |
| 700 | 1 | _aJoven, B | |
| 700 | 1 | _aLázaro, P | |
| 700 | 1 | _aOlveira, A | |
| 700 | 1 | _aQuintero, J | |
| 700 | 1 | _aRivera, R | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 32 _gno. 12 _gp. 2058-2073 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jdv.15177 _zAvailable from publisher's website |
| 999 |
_c28618552 _d28618552 |
||